Nature vs Science Advances: Choosing the Right Tier for Your Paper

Nature's current JIF (56.1) is roughly 4x higher than Science Advances (13.9). This reflects a real difference in citation density and selectivity, but it does not make Science Advances low-impact. Science Advances remains a Q1 multidisciplinary journal and a credible high-impact open-access target.

Prestige-wise: Nature is a top-tier career boost. Science Advances is a strong, credible publication that strengthens applications and grant proposals, but without quite the same prestige halo as Nature.

Nature is asking: "Does this paper fundamentally change how the field thinks?" Editors are looking for conceptual breakthroughs, paradigm shifts, or research that will be foundational. The bar is extremely high. Nature says only about 8% of submissions are accepted, and most submissions are declined without peer review.

Science Advances is asking: "Is this original, rigorous, and significant research that advances the field?" The bar is still very high, but "significant" does not require "paradigm-shifting." Good, novel work that makes a real contribution can land here. Treat the commonly repeated 10% acceptance figure as planning context unless you have a current AAAS source for your exact article class.

Practical difference: A mechanistic study of a disease protein might be desk-rejected at Nature as too specialized. It could be a solid Science Advances paper.

Both journals are openly multidisciplinary and accept work from all sciences. Nature perhaps leans slightly toward biology and medicine in what gets published, while Science Advances is more evenly distributed. But both accept physics, chemistry, engineering, and other fields.

No meaningful difference in scope - this decision factor shouldn't drive your choice.

This comparison has a significant cost dimension that most comparison articles ignore.

Science Advances: $5,450 APC for every published paper, before eligible institutional or membership discounts. This is mandatory because there is no subscription route. Verify the current AAAS charge and discount status during the submission or payment workflow before budgeting.

Nature: $0 for subscription publication. $12,850 for gold OA in current Nature publishing-options context. Most Nature authors can still publish behind the paywall at no author fee. If your funder mandates immediate OA, the OA cost is a real budget line item unless an institutional Springer Nature agreement covers it.

The cost difference matters: if you publish in Science Advances, you are paying $5,450 before discounts. If you publish in Nature under subscription, you are paying $0. For budget-constrained labs, Nature is actually the cheaper option if you can get in. For labs with immediate OA mandates, Science Advances is significantly cheaper than Nature's current $12,850 gold OA option.

In our review work comparing Nature and Science Advances submission choices, the most common wrong move is not aiming too high. It is confusing the kind of breadth each journal needs. We reviewed this page to help authors make the journal decision before they submit, when the title, abstract, first figure, cover letter, and APC plan can still be changed.

Nature overreach with a Science Advances-shaped paper. We see technically strong papers that make a genuine interdisciplinary contribution but still need the home-field setup to explain why the result matters. Those manuscripts often lose a week to a predictable Nature desk decision, then submit nearly unchanged to Science Advances. The better move is to decide earlier whether the title, abstract, first figure, and summary paragraph already travel outside the home field.

Science Advances self-downgrade with a Nature-shaped result. The reverse also happens. Some teams avoid Nature because the odds look brutal, even when the paper has a compact claim, decisive evidence, and obvious relevance to scientists one field away. If the abstract can explain the cross-field consequence without specialist setup, and the first figure demonstrates rather than merely introduces the claim, a fast Nature attempt can be rational before Science Advances.

Cost-driven journal choice before fit-driven journal choice. APCs matter, but the first decision should be fit. A $5,450 Science Advances APC is not efficient if the paper belongs in PNAS or a field journal. A $0 Nature subscription route is not efficient if the manuscript is clearly going to fail the flagship breadth screen. We check the cover letter and data-availability plan separately because a funder-mandated OA requirement can change the best route even when the science fit is unchanged.

Use the comparison as a routing test: Nature first only when the broad consequence is obvious in the title, summary paragraph, and first figure; Science Advances when the paper is high-quality, interdisciplinary, and important, but not a flagship event. The practical test is whether an editor can repeat the paper's consequence without rereading the introduction, methods, or specialist background.

Nature lists 8 median days from submission to first editorial decision. If you are rejected, the feedback is often minimal, usually a brief note saying the paper does not meet the significance threshold. This tells you little about what is technically wrong; it tells you a lot about how the editors perceive the paper's breadth and immediate consequence.

Science Advances is more likely to send strong fit papers into full review. If you are rejected after review, you will get detailed reviewer comments that can strengthen your next submission. If you are desk-rejected, the feedback is slightly more informative than Nature's.

The practical implication: If you're between these two journals and you value reviewer feedback as a development tool (early-career researchers, first paper in a new field), Science Advances gives you a better chance of getting useful reviews even in rejection. Nature's desk rejection, while faster, provides almost no actionable information.

Ask yourself honestly:

• Is this work paradigm-shifting? Will it reshape how the field thinks about a fundamental question? If yes, Nature. If no, consider Science Advances.

• How novel is the contribution? Is it a first-in-field advance or an important incremental step? First-in-field: Nature-range. Important incremental: Science Advances.

• How much validation do you have? Nature expects overwhelming evidence. Science Advances is satisfied with solid, rigorous evidence. If your data is comprehensive, Nature. If it's solid but not overwhelming, Science Advances.

• Can you afford open access fees? Science Advances will cost money. Nature doesn't, unless you choose open access.

• Do you want feedback if rejected? Science Advances sends more to review and gives more feedback. Nature desk rejects more but with less explanation.

Many authors submit to Nature first. If desk-rejected, they ask: is this paper weaker than I thought, or just not Nature-level? If the rejection feedback suggests the work is solid but not paradigm-shifting, Science Advances is a logical next target. The paper won't need major revision - just reframing.

But don't force a Nature submission for a paper that fits Science Advances better. You'll waste time and face a second rejection.

Nature-level work:

• Discovery of a completely new cellular mechanism

• First demonstration of a principle in a new domain

• Evidence that overturns a long-held model

• Breakthrough therapeutic approach with mechanism and clinical proof

Science Advances-level work:

• Novel mechanistic insight into a known process

• Important incremental advance in a field

• First application of a technique to a new system with strong results

• Solid translational research with good validation

Nature is worth submitting to if you genuinely believe your work is paradigm-shifting. But don't force a Nature submission just for the JIF. If you're uncertain, Science Advances is an excellent home for solid, high-impact research. Publishing in Science Advances strengthens your career and disseminates your work to a broad audience. It's not "settling" - it's being strategic about where your paper is most likely to be accepted and reach the right readers.

The biggest risk is the opposite: hesitating to submit to Nature when your work actually does belong there. If you're uncertain, submit to Nature first and see what the editors say. Rejection is information; use it to guide your next submission.

Want a quick read on whether your manuscript is positioned for Nature or better suited to Science Advances? A Nature vs. Science Advances scope check evaluates scope, novelty framing, and readiness for your target journal. The scan takes about two to three minutes and is free.

If Nature desk-rejects your paper, the editors may suggest transferring to another Nature Portfolio journal. The most common cascades for multidisciplinary work:

Science Advances does not participate in the Nature transfer system (different publisher). If Nature rejects, you'd need to resubmit to Science Advances separately. But the paper rarely needs major reformatting, both journals accept similar formats.

A Nature vs. Science Advances scope check can identify whether your paper is positioned for Nature's paradigm-shifting bar or Science Advances' significant-advance bar before you commit to a submission cycle.

1. Science Advances citation-metric context

1. Science Advances guide for authors